Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Gonadal hormone fluctuations do not affect the expression or extinction of fear-potentiated startle in female rats.

Voulo ME, Parsons RG.

Behav Neurosci. 2019 Jun 27. doi: 10.1037/bne0000324. [Epub ahead of print]

PMID:
31246079
2.

Subthreshold Fear Conditioning Produces a Rapidly Developing Neural Mechanism that Primes Subsequent Learning.

Cole KE, Lee J, Davis M, Parsons RG.

eNeuro. 2019 Jun 27;6(3). pii: ENEURO.0113-19.2019. doi: 10.1523/ENEURO.0113-19.2019. Print 2019 May/Jun.

3.

Individual variability in the recall of fear extinction is associated with phosphorylation of mitogen-activated protein kinase in the infralimbic cortex.

Russo AS, Lee J, Parsons RG.

Psychopharmacology (Berl). 2019 Jul;236(7):2039-2048. doi: 10.1007/s00213-019-05195-2. Epub 2019 Feb 23.

PMID:
30798403
4.

Facilitation of fear learning by prior and subsequent fear conditioning.

Lee J, Russo AS, Parsons RG.

Behav Brain Res. 2018 Jul 16;347:61-68. doi: 10.1016/j.bbr.2018.03.008. Epub 2018 Mar 7.

PMID:
29524449
5.

Regulation of actions and habits by ventral hippocampal trkB and adolescent corticosteroid exposure.

Barfield ET, Gerber KJ, Zimmermann KS, Ressler KJ, Parsons RG, Gourley SL.

PLoS Biol. 2017 Nov 29;15(11):e2003000. doi: 10.1371/journal.pbio.2003000. eCollection 2017 Nov.

6.

Behavioral and neural mechanisms by which prior experience impacts subsequent learning.

Parsons RG.

Neurobiol Learn Mem. 2018 Oct;154:22-29. doi: 10.1016/j.nlm.2017.11.008. Epub 2017 Nov 16.

PMID:
29155095
7.

Successful pharmacotherapy for the treatment of severe feeding aversion with mechanistic insights from cross-species neuronal remodeling.

Sharp WG, Allen AG, Stubbs KH, Criado KK, Sanders R, McCracken CE, Parsons RG, Scahill L, Gourley SL.

Transl Psychiatry. 2017 Jun 20;7(6):e1157. doi: 10.1038/tp.2017.126.

8.

Response-specific sex difference in the retention of fear extinction.

Voulo ME, Parsons RG.

Learn Mem. 2017 May 15;24(6):245-251. doi: 10.1101/lm.045641.117. Print 2017 Jun.

9.

Acoustic startle response in rats predicts inter-individual variation in fear extinction.

Russo AS, Parsons RG.

Neurobiol Learn Mem. 2017 Mar;139:157-164. doi: 10.1016/j.nlm.2017.01.008. Epub 2017 Jan 25.

PMID:
28131759
10.

Mechanisms underlying long-term fear memory formation from a metaplastic neuronal state.

Parsons RG, Walker DL, Davis M.

Neurobiol Learn Mem. 2016 Dec;136:47-53. doi: 10.1016/j.nlm.2016.09.009. Epub 2016 Sep 19.

PMID:
27660077
11.

Differential expression of cytoskeletal regulatory factors in the adolescent prefrontal cortex: Implications for cortical development.

Shapiro LP, Parsons RG, Koleske AJ, Gourley SL.

J Neurosci Res. 2017 May;95(5):1123-1143. doi: 10.1002/jnr.23960. Epub 2016 Oct 13. Review.

12.

Memory accuracy predicts hippocampal mTOR pathway activation following retrieval of contextual fear memory.

Gafford GM, Parsons RG, Helmstetter FJ.

Hippocampus. 2013 Sep;23(9):842-7. doi: 10.1002/hipo.22140. Epub 2013 Jun 4.

13.

Implications of memory modulation for post-traumatic stress and fear disorders.

Parsons RG, Ressler KJ.

Nat Neurosci. 2013 Feb;16(2):146-53. doi: 10.1038/nn.3296. Epub 2013 Jan 28. Review.

14.

The timing of multiple retrieval events can alter GluR1 phosphorylation and the requirement for protein synthesis in fear memory reconsolidation.

Jarome TJ, Kwapis JL, Werner CT, Parsons RG, Gafford GM, Helmstetter FJ.

Learn Mem. 2012 Jun 20;19(7):300-6. doi: 10.1101/lm.024901.111.

15.

A metaplasticity-like mechanism supports the selection of fear memories: role of protein kinase a in the amygdala.

Parsons RG, Davis M.

J Neurosci. 2012 Jun 6;32(23):7843-51. doi: 10.1523/JNEUROSCI.0939-12.2012.

16.

Gone but not Forgotten.

Parsons RG, Davis M.

Front Behav Neurosci. 2011 Aug 18;5:51. doi: 10.3389/fnbeh.2011.00051. eCollection 2011. No abstract available.

17.

Consolidation and reconsolidation of contextual fear memory requires mammalian target of rapamycin-dependent translation in the dorsal hippocampus.

Gafford GM, Parsons RG, Helmstetter FJ.

Neuroscience. 2011 May 19;182:98-104. doi: 10.1016/j.neuroscience.2011.03.023. Epub 2011 Mar 22.

18.

Temporary disruption of fear-potentiated startle following PKMĪ¶ inhibition in the amygdala.

Parsons RG, Davis M.

Nat Neurosci. 2011 Mar;14(3):295-6. doi: 10.1038/nn.2745. Epub 2011 Jan 23. Erratum in: Nat Neurosci. 2011 Dec;14(12):1617.

19.

Regulation of extinction-related plasticity by opioid receptors in the ventrolateral periaqueductal gray matter.

Parsons RG, Gafford GM, Helmstetter FJ.

Front Behav Neurosci. 2010 Aug 3;4. pii: 44. doi: 10.3389/fnbeh.2010.00044. eCollection 2010.

20.

Macromolecular synthesis, distributed synaptic plasticity, and fear conditioning.

Helmstetter FJ, Parsons RG, Gafford GM.

Neurobiol Learn Mem. 2008 Mar;89(3):324-37. Epub 2007 Oct 31. Review.

22.

The formation of auditory fear memory requires the synthesis of protein and mRNA in the auditory thalamus.

Parsons RG, Riedner BA, Gafford GM, Helmstetter FJ.

Neuroscience. 2006 Sep 1;141(3):1163-70. Epub 2006 Jun 12.

23.

Long-term stability of fear memory depends on the synthesis of protein but not mRNA in the amygdala.

Parsons RG, Gafford GM, Baruch DE, Riedner BA, Helmstetter FJ.

Eur J Neurosci. 2006 Apr;23(7):1853-9.

24.

Effects of post-training hippocampal injections of midazolam on fear conditioning.

Gafford GM, Parsons RG, Helmstetter FJ.

Learn Mem. 2005 Nov-Dec;12(6):573-8.

25.

Physician self-referral for diagnostic imaging: review of the empiric literature.

Kouri BE, Parsons RG, Alpert HR.

AJR Am J Roentgenol. 2002 Oct;179(4):843-50. Review. No abstract available.

PMID:
12239022
26.

Multianalyte assay system developed for drugs of abuse.

Parsons RG, Kowal R, LeBlond D, Yue VT, Neargarder L, Bond L, Garcia D, Slater D, Rogers P.

Clin Chem. 1993 Sep;39(9):1899-903. Erratum in: Clin Chem 1993 Nov;39(11 Pt 1):2343.

27.

Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.

Benjamin D, Magrath IT, Maguire R, Janus C, Todd HD, Parsons RG.

J Immunol. 1982 Sep;129(3):1336-42.

PMID:
6286763
28.

A comparison of DNA and DNA-binding protein levels in malignant disease.

Leon SA, Shapiro B, Servi P, Parsons RG.

Eur J Cancer. 1981 May;17(5):533-8. No abstract available.

PMID:
6895357
29.

A stable, sensitive assay for human fibronectin.

Todd-Kulikowski HD, Parsons RG.

J Immunol Methods. 1981;44(3):333-41.

PMID:
7276583
30.

Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseases.

Todd HD, Coffee MS, Waalkes TP, Abeloff MD, Parsons RG.

J Natl Cancer Inst. 1980 Nov;65(5):901-4.

PMID:
6253707
31.

Stabilization of proteins immobilized on Sepharose from leakage by glutaraldehyde crosslinking.

Kowal R, Parsons RG.

Anal Biochem. 1980 Feb;102(1):72-6. No abstract available.

PMID:
6243888
32.
33.

Detection of a human serum DNA-binding protein associated with malignant disease.

Parsons RG, Aldenderfer PH, Kowal R.

J Natl Cancer Inst. 1979 Jul;63(1):43-7.

PMID:
221718
34.

Solid phase lactoperoxidase radioiodination of microgram quantities of protein mixtures for electrophoretic analysis.

Parsons RG, Kowal R.

Anal Biochem. 1979 Jun;95(2):568-74. No abstract available.

PMID:
222168
35.

Serum ribonuclease activity in cancer patients.

Kottel RH, Hoch SO, Parsons RG, Hoch JA.

Br J Cancer. 1978 Aug;38(2):280-6.

36.

A correlation of serum C3DP levels with chemotherapeutic management of cancer patients.

Parsons RG, Hoch JA, Longmire RL.

Cancer. 1978 Jun;41(6):2099-106.

PMID:
657083
37.

A clinical evaluation of serum C3DP levels in individuals with malignant diseases.

Parsons RG, Longmire RL, Hoch SO, Hoch JA.

Cancer Res. 1977 Mar;37(3):692-5.

38.
39.

Letter: Crystallographic data of an L-arabinose-binding protein from Escherichia coli.

Quiocho FA, Phillips GN Jr, Parsons RG, Hogg RW.

J Mol Biol. 1974 Jun 25;86(2):491-3. No abstract available.

PMID:
4606729
40.

Crystallization and characterization of the L-arabinose-binding protein of Escherichia coli B-r.

Parsons RG, Hogg RW.

J Biol Chem. 1974 Jun 10;249(11):3602-7. No abstract available.

41.

A comparison of the L-arabinose- and D-galactose-binding proteins of Escherichia coli B-r.

Parsons RG, Hogg RW.

J Biol Chem. 1974 Jun 10;249(11):3608-14. No abstract available.

42.

Tetanus, a severe case with recovery.

TAYLOR FB, PARSONS RG, HANSEN HE.

Ann Intern Med. 1951 Nov;35(5):1134-7. No abstract available.

PMID:
14885893

Supplemental Content

Loading ...
Support Center